Cancer Type/Condition: Brain tumor, adult: General and other
Stage/Subtype: medulloblastoma, adult
Country: U.S.A.
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 2 to 32 Sponsor: Pharmaceutical / Industry Protocol IDs: CNS 0201, NCT00179907
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 1 to 30 Sponsor: Other Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NU 10C03, STU00040150, NCT01325207
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: 05-122, MSKCC-05122, NCT00445965
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000066489, BC-BT-9, NCT00003457
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000066512, BC-BT-21, NCT00003475
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 3 to 25 Sponsor: NCI, Other Protocol IDs: 09-361, P01CA021239, NCT01063114
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 3 to 25 Sponsor: Other Protocol IDs: 06-1151, NCT01542736
|
|
9.
|
Phase: Phase I Type: Treatment Status: Active Age: 3 to 70 Sponsor: Other Protocol IDs: MCW-7594, MCW-CHW-511, MCW-CHW-9411, NCI-V95-0652, NCT00002647
|
|
10.
|
Phase: Phase I Type: Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: 03-133, P30CA008748, MSKCC-03133, NCT00089245
|
|
11.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: DTI-021, 5R43CA132257-02, NCT01048008
|
|
12.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI Protocol IDs: 110047, 11-C-0047, NCT01259479
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 191511, NCI-2011-03568, NCT01522820
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|